Abstract
This study aimed to evaluate the effectiveness of the clinical nursing pathway model in the care of patients with mild acute pancreatitis (MAP). We conducted a retrospective analysis of medical records for 80 patients diagnosed with MAP at our hospital between September 2021 and March 2023. The patients were randomly assigned to 2 groups: the control group, which received routine nursing care, and the observation group, which followed the clinical nursing pathway. The primary outcomes assessed were the time to symptom relief, recovery time from gastrointestinal bloating, emotional status, blood biochemical indicators, self-efficacy, self-care ability, and quality of life. The observation group experienced significantly shorter times for the resolution of abdominal pain and bloating, normalization of serum/urine amylase levels, and anal exhaust compared to the control group (P < .05). Additionally, the observation group reported lower scores on the self-rating anxiety scale and self-rating depression scale, and higher scores on the General Self-Efficacy Scale (P < .05). Biochemical analysis revealed that the levels of serum amylase, lipase, and C-reactive protein were significantly lower in the observation group (P < .05). Moreover, the observation group showed significantly higher scores for self-care ability and overall quality of life compared to the control group (P < .05). The clinical nursing pathway model significantly enhances the quality of care for patients with MAP by accelerating symptom relief, improving emotional status, reducing biochemical markers, and enhancing quality of life. This model effectively promotes both physical and mental health, increases self-care ability, and offers substantial potential for broader application in clinical practice.